Avivagen Inc VIVXF

Consumer Defensive Farm Products

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.

GREY:VIVXF - Post by User

Avivagen Inc

Bullboard Posts

Comment by Ibuyvalueon Apr 26, 2018 3:11pm

39 Views

Post# 27946156

RE:Avivagen OxC-Beta intrduction-inclusion-adoption disruption

it is important to have a realistic view of the profit potential before deciding if a stock is worthy of investing in... then you look at valuation and decide if there is a probabilty of earning a return that will compensate the risk you are taking.

at 25-30M$ of mkt cap... it may be cheap... but as a company that has not demonstrated its earnings potential in the past 5 to 10 years...one has to be careful before dreaming of big numbers.

the adoption of the product has been very slow...and not profitable sor far...

lets see more sales volume before dreaming to big!

Bullboard Posts

Anaergia expands relationship with PepsiCo